A practical hand from a friend

Write to the people who can answer.

A short, personal message can help make the funding pathway clearer. Use these as a starting point and put it in your own words. Please don’t send Denis’s NHI number, scans, or private records through general email or public forms.

Funding and access

Pharmac

Ask about the current funding position, any supplier application, and the next steps. Pharmac says only an authorised prescriber can submit an individual NPPA application; the general public can ask questions or make a wider medicine funding application.

Email: enquiry@pharmac.govt.nz
Phone: 0800 660 050
Post: Pharmac, PO Box 10254, The Terrace, Wellington 6143

Email Pharmac Pharmac consumer application NPPA information for clinicians

Kia ora Pharmac,

I’m writing as a friend of someone in Aotearoa with ALK-positive advanced lung cancer. His oncologist has recommended lorlatinib. I understand an individual NPPA application must come from an authorised prescriber, so I’m not asking you to discuss his confidential case with me.

Could you please clarify lorlatinib’s current funding status in New Zealand, whether there is a current supplier funding application, and what evidence or next steps remain for wider assessment? Please also point me to the right information for his oncology team about individual access.

Thank you,
[Your name]

Medicine supplier

Pfizer New Zealand

Ask where to find current New Zealand information about Lorviqua (lorlatinib), availability, patient support pathways, and whether Pfizer has submitted a funding application. Pfizer can provide product information; treatment decisions remain with Denis and his clinical team.

Medical Information: 0800 736 363
Official contact page: pfizer.co.nz/contacts
Postal: Pfizer New Zealand, PO Box 3998, Shortland Street, Auckland 1140

Contact Pfizer NZ Pfizer Medical Information

Kia ora Pfizer New Zealand,

I’m supporting a friend with ALK-positive advanced lung cancer whose oncologist has recommended lorlatinib. I understand treatment decisions are for him and his clinical team.

Could you direct me to current New Zealand information about Lorviqua availability and patient support, and let me know whether Pfizer has submitted or plans to submit a funding application to Pharmac for this indication? If there is a public update or the right patient/whānau contact pathway, please share it.

I’m not including personal health information in this message. Thank you.

[Your name]

Elected representatives

Your MP and the Minister of Health

Ask your MP to raise questions and request a clear public explanation. The Minister can be asked about the Government’s response. Pharmac makes funding decisions under its own process; neither an MP nor a minister can promise an individual funding outcome.

Find MPs and their contact details Email Hon Simeon Brown, Minister of Health

Minister of Health (checked 1 October 2026): Hon Simeon Brown
Email: S.Brown@ministers.govt.nz · official profile

Letters to an MP:
[MP’s name]
Freepost Parliament
Private Bag 18 888
Parliament Buildings
Wellington 6160

Use your own MP’s contact page for email. Names and portfolios can change, so check the current official directory. This postal address is the Parliament Freepost service for letters.

Kia ora [MP / Minister],

I’m writing as a [constituent / supporter] of Denis, known to his mates as Denk. His oncologist has recommended lorlatinib for ALK-positive advanced lung cancer. Our family and friends are trying to understand the New Zealand access pathway.

Could you please ask Pharmac for a clear public update on lorlatinib’s current funding status, any supplier application, and the evidence and next steps still required? I’d also like to know how patients and whānau can share their experience.

I understand individual care decisions belong with Denis and his clinicians, and funding decisions are made through Pharmac’s process. I’m asking for transparency and a clear pathway, not a promised outcome.

Thank you,
[Your name]
[Suburb / electorate]

Local community

Your city or district council

New Zealand doesn’t have state governments. Councils do not decide medicine funding, but they may help with a local awareness event, community notice, venue, or introductions to local organisations. Ask the council where Denis lives or where the campaign is based.

Find a local council

Kia ora [Mayor / Councillor / Community Partnerships team],

I’m a local resident and a friend of Denis, known to his mates as Denk. I’m organising community support for his family while they navigate a serious cancer diagnosis and treatment access.

I know medicine funding is a national matter, not a council decision. Could you let me know whether council can help with [a community venue / sharing an approved notice / connecting us with local groups]? We will use information approved by Denis and his whānau.

Thank you,
[Your name]
[Suburb]

Petition

There is no live petition yet

The wording is drafted, but a named petitioner needs to submit it to Parliament. The petitioner’s name is published, and Parliament moderates the request. Supporters can sign once an approved petition is open. An MP must agree to present it after it closes; signatures do not guarantee a policy or funding change.

Review petition wording and launch steps

Official contact routes and postal details checked 1 October 2026. Please personalize your message and send it once; thoughtful questions are more useful than repeated identical emails.

Back to Denis (Denk)’s campaign